Completed
Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study
NCT04270760
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
- Locations
-
- Westside Medical Associates of Los Angeles Beverly Hills, California, United States
- Excel Medical Clinical Trials Boca Raton, Florida, United States
- Piedmont Healthcare Atlanta, Georgia, United States
- University of Kansas Medical Center Kansas City, Kansas, United States